Quantinuum Inc. Class A Common Stock
QNT
$54.88
-6.32%
Quantinuum Inc. is a full-stack quantum computing company that develops hardware, software, and applications to scale quantum technology. As a spin-off from Honeywell, it holds a unique position as a vertically integrated quantum player with deep corporate backing. The stock has recently attracted attention following Honeywell's structural shakeup and the broader quantum sector's government funding tailwinds, though it remains a highly speculative, pre-revenue growth story.…
QNT
Quantinuum Inc. Class A Common Stock
$54.88
Related headlines
Investment Opinion: Should I buy QNT Today?
Rating: Hold. Quantinuum is a speculative pre-revenue quantum computing stock with a strong balance sheet but deteriorating fundamentals. The analyst consensus average target of $98.75 implies 76% upside, but the stock's 72.6% revenue decline and extreme PS ratio of 64.8x warrant caution. The recommendation is a Hold, as the risk/reward is balanced but tilted negative near-term.
Supporting Evidence: The primary valuation metric, PS ratio, is 64.8x trailing and 44.6x forward, both extremely high. Revenue growth is negative (-72.6% YoY), and the company is deeply unprofitable with a net margin of -312%. Free cash flow is negative $85.6 million, though the company has zero debt and $677 million cash. The implied upside to the average analyst target is 76.1%, but the wide range ($78-$155) reflects high uncertainty. Compared to industry averages (not provided), the PS ratio is likely several times higher than mature tech peers.
Risks & Conditions: The biggest risks are continued revenue decline, cash burn, and valuation compression. This Hold would upgrade to Buy if the company shows sequential revenue growth and gross margin stabilization above 70%, or if the stock pulls back to the 52-week low of $50.10, offering a better entry. It would downgrade to Sell if revenue continues to decline and cash burn accelerates, or if the stock breaks below $50.10 on high volume. Overall, Quantinuum appears overvalued relative to its current financial performance but fairly valued if one believes in the long-term quantum opportunity.
Sign up to view all
QNT 12-Month Price Forecast
The outlook for Quantinuum over the next 12 months is highly uncertain. The base case of gradual progress and a target of $98.75 is most likely (50% probability), but the bear case of continued decline is equally probable as the bull case. The stock's extreme valuation and negative momentum make it a high-risk bet. A shift to bullish would require clear evidence of revenue stabilization and a catalyst like a major contract. A shift to bearish would occur if cash burn accelerates or the stock breaks below $50.10.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Quantinuum Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $98.75 and implied upside of +79.9% versus the current price.
Average Target
$98.75
0 analysts
Implied Upside
+79.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$78 - $155
Analyst target range
Quantinuum is covered by 12 analysts, with a consensus average price target of $98.75, implying 76.1% upside from the current price of $56.07. The target range spans from $78.00 (low) to $155.00 (high), indicating a wide dispersion of views. The high target of $155.00 assumes successful quantum commercialization and multiple expansion, while the low target of $78.00 reflects risks of delayed adoption or competitive pressure. The consensus recommendation is not provided, but the average target suggests a bullish tilt. The wide spread between low and high targets (77 points) signals high uncertainty, typical for early-stage quantum stocks. No recent upgrades or downgrades are available in the data, but the stock's post-IPO decline may attract contrarian analyst attention.
Bulls vs Bears: QNT Investment Factors
Quantinuum presents a high-risk, high-reward profile typical of early-stage quantum computing companies. The bull case rests on a strong balance sheet, analyst optimism, and Honeywell's backing, while the bear case is driven by a 72.6% revenue decline, extreme valuation multiples, and rapid cash burn. The single most important tension is whether the company can reverse its revenue trajectory and demonstrate commercial traction before its cash runway depletes. Currently, the bearish evidence is stronger due to deteriorating fundamentals and negative price momentum, but the wide analyst target range reflects extreme uncertainty.
Bullish
- Strong Cash Position with Zero Debt: Quantinuum holds $677 million in cash with a debt-to-equity ratio of 0.006, providing a substantial runway to fund R&D and operations without financial distress. This financial strength is rare for a pre-revenue company and reduces bankruptcy risk.
- Analyst Consensus Implies 76% Upside: The average analyst price target is $98.75, representing 76.1% upside from the current price of $56.07. Even the low target of $78.00 implies a 39% gain, suggesting analysts see significant value despite recent declines.
- Honeywell Backing and Government Tailwinds: As a Honeywell spin-off, Quantinuum benefits from deep corporate support and credibility. Recent government funding of $100 million to quantum peers highlights sector tailwinds, and Honeywell's structural shakeup may unlock further value.
- High Gross Margin Indicates Scalable Technology: Despite revenue decline, gross margin remains high at 65.1% in Q1 2026, though down from 92.3% a year ago. This suggests the core technology has strong unit economics that could improve with scale.
Bearish
- Revenue Collapse of 72.6% YoY: Q1 2026 revenue was only $5.24 million, down from $19.09 million in Q1 2025, a 72.6% decline. This severe drop raises questions about product-market fit and near-term demand for quantum solutions.
- Extreme Valuation at 64.8x Sales: The trailing PS ratio of 64.8x is astronomically high for a company with declining revenue. Even the forward PS of 44.6x assumes revenue growth that has not materialized, leaving the stock vulnerable to multiple compression.
- Massive Cash Burn with Negative Free Cash Flow: Free cash flow was negative $85.6 million in Q1 2026, and operating cash flow was negative $62.9 million. At this burn rate, the $677 million cash pile provides only about 2 years of runway, pressuring the company to achieve milestones quickly.
- Stock in Clear Downtrend with 32.6% Drawdown: Since listing on June 4, 2026, the stock has declined 7.1% and experienced a maximum drawdown of -32.58%. The 1-month price change is -10.65%, and relative strength vs. S&P 500 is -10.96%, indicating persistent selling pressure.
QNT Technical Analysis
Quantinuum has been in a clear downtrend since its listing on June 4, 2026, with the stock declining 7.1% from its first close of $60.38 to $56.07 as of July 17, 2026. The current price sits at 56.07, which is 64.6% of its 52-week range (low $50.10, high $86.79), indicating it is closer to the lows and reflecting bearish sentiment. The 1-year price change is not available due to the short trading history, but the stock has already experienced a maximum drawdown of -32.58% from its peak. Short-term momentum is decisively negative: the 1-month price change is -10.65%, and the 3-month change (since listing) is -7.1%, with the stock losing ground in 4 of the last 5 trading sessions. The relative strength versus the S&P 500 over 1 month is -10.96%, confirming significant underperformance. The 52-week low of $50.10 provides immediate support, while the 52-week high of $86.79 is the key resistance. A break below $50.10 would signal further downside, while a move above $86.79 would indicate a reversal. Beta is not provided, but the stock's high volatility is evident from its wide daily swings and -32.58% max drawdown in just over a month.
Beta
—
—
Max Drawdown
-34.0%
Largest decline past year
52-Week Range
$50-$87
Price range past year
Annual Return
—
Cumulative gain past year
| Period | QNT Return | S&P 500 |
|---|---|---|
| 1m | -19.6% | +0.4% |
| 3m | — | +5.5% |
| 6m | — | +8.4% |
| 1y | — | +18.9% |
| ytd | — | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QNT Fundamental Analysis
Quantinuum is a pre-revenue company with minimal sales: Q1 2026 revenue was just $5.24 million, down 72.6% from $19.09 million in Q1 2025, indicating a severe revenue decline. The company is not generating meaningful top-line growth, and the investment case hinges on future quantum computing adoption rather than current financial performance. The company is deeply unprofitable, with a net loss of $16.74 million in Q1 2026, though this loss narrowed from $30.49 million in Q1 2025. Gross margin was 65.1% in Q1 2026, down from 92.3% a year ago, reflecting higher cost of goods sold relative to revenue. Operating margin was -2629% in Q1 2026, driven by R&D expenses of $74.7 million and SG&A of $62.2 million, far exceeding revenue. The balance sheet shows a strong cash position of $677 million as of Q1 2026, with zero debt (debt-to-equity ratio of 0.006). However, free cash flow was negative $85.6 million in Q1 2026, and operating cash flow was negative $62.9 million, indicating the company is burning cash to fund operations. ROE is -4.2%, reflecting the net loss relative to equity. The company has ample liquidity (current ratio of 14.25) but is not self-sustaining.
Quarterly Revenue
$5237000.0B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
65.1%
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QNT Overvalued?
Since net income is negative, the price-to-sales (PS) ratio is the primary valuation metric. The trailing PS ratio is 64.8x based on the last twelve months' revenue, while the forward PS ratio (using estimated revenue of $44.95 million) is approximately 44.6x. The gap between trailing and forward PS suggests the market expects revenue growth, though the recent quarterly decline raises questions. Compared to the industry average (not provided), a PS of 64.8x is extremely high, indicating a premium typically reserved for high-growth or disruptive companies. Historical PS ratios show a decline from 399.7x in Q1 2026 to 64.8x currently, reflecting the stock's price drop and minimal revenue. The current PS is near the lower end of its short history, suggesting the market is pricing in less optimism than at listing. The PEG ratio of 0.58 is misleading due to negative earnings, and the EV/Sales of 1,043x is astronomically high, reflecting the company's minimal revenue relative to enterprise value.
PE
-28.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-2.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Quantinuum's primary financial risk is its severe revenue decline of 72.6% YoY to $5.24 million, combined with a net loss of $16.74 million in Q1 2026. The company burns cash rapidly, with negative free cash flow of $85.6 million in the quarter, and despite $677 million in cash, the burn rate implies a runway of roughly 2 years. The gross margin dropped from 92.3% to 65.1%, indicating cost pressures, and the operating margin of -2629% shows that R&D and SG&A expenses far exceed revenue. Any delay in revenue growth could force dilutive financing or cost cuts.
Market & Competitive Risks: The stock trades at a trailing PS ratio of 64.8x, which is extremely high even for growth stocks, making it vulnerable to valuation compression if sentiment shifts. The quantum computing sector is highly competitive, with well-funded players like Rigetti and D-Wave also vying for government contracts and commercial adoption. The stock's beta is not provided, but its high volatility and -32.58% drawdown suggest significant macro sensitivity. Recent news of government funding for competitors highlights that Quantinuum may not be the sole beneficiary of sector tailwinds.
Worst-Case Scenario: In a worst-case scenario, continued revenue decline, missed milestones, and a broader tech selloff could drive the stock to its 52-week low of $50.10, representing a 10.6% downside from the current price. If the company fails to secure additional funding or commercial contracts, the stock could fall further, potentially to the analyst low target of $78.00? Actually the low target is $78.00, which is above current price, but that is a target, not a downside scenario. A realistic worst-case could see the stock testing the $50.10 low or even lower if cash burn accelerates. An investor could lose up to 10.6% to the 52-week low, but given the speculative nature, losses could exceed 30% if the quantum hype fades.
FAQ
The key risks are: 1) Financial: revenue decline of 72.6% YoY and negative free cash flow of $85.6 million per quarter, leading to potential cash crunch. 2) Valuation: PS ratio of 64.8x leaves little room for error. 3) Competitive: well-funded rivals like Rigetti and D-Wave also target government contracts. 4) Company-specific: dependence on Honeywell support and quantum technology commercialization. The most severe risk is continued revenue decline, which could drive the stock to the 52-week low of $50.10 or lower.
The 12-month forecast is highly uncertain. The base case (50% probability) sees the stock reaching the analyst average target of $98.75, driven by gradual progress. The bull case (25% probability) targets $155.00 on major catalysts, while the bear case (25% probability) sees the stock falling to $50.10-$78.00 if revenue continues to decline. The most likely scenario is the base case, but the wide range reflects extreme uncertainty. Investors should monitor quarterly results for signs of revenue stabilization.
Quantinuum appears overvalued based on current financials, with a trailing PS ratio of 64.8x and negative earnings. However, the forward PS ratio of 44.6x assumes revenue growth that has not materialized. Compared to the industry average (not provided), this multiple is extremely high. The market is pricing in significant future growth, which makes the stock vulnerable to multiple compression if growth disappoints. The stock is likely overvalued relative to its current performance but could be fairly valued if quantum computing adoption accelerates.
Quantinuum is a high-risk, high-reward speculative stock. The analyst average target of $98.75 implies 76% upside, but the stock has declined 7.1% since listing and faces a 72.6% revenue decline. It may be a good buy for investors with a long-term horizon who believe in quantum computing and can tolerate significant volatility, but it is not suitable for conservative or short-term investors. The risk/reward is balanced, but the current downtrend and weak fundamentals suggest waiting for a better entry point near the 52-week low of $50.10.
Quantinuum is better suited for long-term investment (5+ years) given its pre-revenue stage and the long timeline for quantum computing commercialization. The stock is highly volatile, with a -32.58% drawdown in just over a month, making it unsuitable for short-term trading unless one can tolerate significant risk. The company has a strong cash position but no dividend, so it is a pure growth play. A minimum holding period of 3-5 years is recommended to allow for potential technological breakthroughs and revenue growth.